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The adherent mucus layer of the gastrointestinal tract plays a vital physiological part as a lubricant and as a protective barrier against luminal contents.' About 1% of the normal human colonic bacterial flora secrete a range of extracellular enzymes, which allow them to utilise mucin as their sole energy source2 and there is a continual balance between the synthesis and secretion of mucus and its breakdown by bacterial glycosidases.3 4 Colonic mucus glycoproteins are heavily sulphated in contrast with mucin from the stomach or small intestine.5 This sulphation confers increased charge, which possibly affects the rheological properties of the mucus but, perhaps more significantly, confers resistance to enzymatic degradation by glycosidases.67 Sulphation of mucins generally correlates with the presence of bacteria as illustrated by increased mucus sulphation in gastric metaplasia occurring in association with achlorhydria,5 in bronchiectasis, and in ileal pouches.8 It seems probable that this may represent an important adaptive response to the presence of bacteria. We have recently shown that enzymatic removal of sulphate ester from colonic mucus increases its susceptibility to degradation by faecal glycosidases and we have also described the identification, purification, and characterisation of a faecal mucin sulphatase,7 the presence of which is probably critical in determining the rate of degradation of secreted mucus in the colon. A hypothesis is therefore proposed that relapse of ulcerative colitis might be related to increased activity of mucin sulphatase and that inhibition of this enzyme could be therapeutically useful. In this study, faecal mucin sulphatase has been assayed in normal subjects and patients with ulcerative colitis and Crohn's disease both in active disease and in remission.
Methods

PATIENTS AND CONTROL SUBJECTS
Faecal samples were collected from 17 healthy volunteers, 22 patients with ulcerative colitis, and 14 patients with Crohn's disease, six with ileocolonic disease and eight with ileal disease. Only three of the ulcerative colitis patients were not receiving sulphasalazine. None of the patients or controls had a history of infective diarrhoea in the previous 12 months and none had received antibiotics within the previous month.
Diagnoses of Crohn's disease or ulcerative colitis were based on conventional pathological and radiological criteria. Clinical information was obtained from the patients by history and examination and information recorded onto a standard protocol. The mean stool frequency in the week before obtaining the sample was recorded. In patients with Crohn's disease the disease activity was assessed by the simple Crohn's disease activity index devised by Harvey and 24 hours at 37°C. The reactants were then applied onto a small gel filtration column (PD-10 G25M, Pharmacia, Milton Keynes, UK) with exclusion size of 5000 daltons. The intact mucus glycoprotein eluted first in the void volume with clear separation from the liberated sulphate and sulphated monosaccharides or oligosaccharides. Recovery of [35S] from the desalting column averaged 98% (range 96-99%). One ml of 0.1 M barium chloride was added to the pooled low molecular weight fractions (total volume 5 ml) to separate by precipitation the free sulphate from any sulphated monosaccharides. The excess barium was precipitated by 1 ml of 0-1 M potassium sulphate and the precipitate centrifuged and washed before resuspension in scintillant for 1 counting on an LKB 1219 Rackbeta (LKB, Turku, Finland). All assays were controlled against heat inactivated samples.
There is no technique that is sufficiently sensitive to permit accurate estimation of the number of sulphated sugar residues per molecule of mucin in the small samples extracted from biopsy specimens. Enzyme activity cannot therefore be expressed conventionally in terms of micromoles of substrate catalysed. One stock sample of 35S mucin was used for all the experiments in the study and enzyme activity was defined arbitrarily as: 1 unit is that enzyme activity which releases 1000 dpm of free sulphate per hour at 37°C. The stock substrate had an activity of 1680 dpmlIpg glycoprotein. The mucin sulphatase assay had an interassay coefficient of variation of 8.8%.
Faecal mucin sulphatase activity was expressed as units/g faecal pellet weight, units/mg protein content, and as ratio of sulphatase/a glucosidase activity.
at GLUCOSIDASE ASSAY a Glucosidase is an ubiquitous bacterial secreted enzyme, which is not relevant to mucus degradation and that may serve as a useful guide to the total faecal bacterial load. a Glucosidase activity was measured using 4- Sigmoidoscopic score (Fig 2) . 1 a significant positive correlation sigmoidoscopic score and faecal m phatase activity (Kendall's t=0.45, (Fig 3) . Of Longitudinal study Seven patients with ulcerative colitis were followed up with serial faecal samples analysed for mucin sulphatase activity. Figure 4 shows the faecal sulphatase activity over the time course and disease activity. In six patients the sulphatase activity closely mirrors clinical disease activity. (Fig 5A) . Sulphatase activity was inhibited 50% by bismuth subcitrate (that tecal is, E50) 1 09 mmolIl and maximal inhibition in excess of 95% was caused by bismuth subciis (n= 12) trate 13 mmol/l (Fig 5B) . Lucin sulBismuth subsalicylate in a suspension of 4 s/g pellet g/l inhibited 950/o of mucin sulphatase activity ared with when continuously agitated. Because of the (median insolubility of the drug, however, it was not [: 22.5 to possible to determine its KEI with any certainty um test). or to ascertain its inhibitor characteristics. The {e ulcera-concentration of this suspension is similar to r than in that used therapeutically in bismuth subsali-/o CI: 8.7 cylate enemas.19 ;e activity Both low molecular weight varieties of detailed sulphated dextrans caused 90% inhibition of described mucin sulphatase activity at a concentration of p<0 01, 50/0 wt/wt. Their inhibition kinetic characterisrhere was tics best fit a non-competitive model. High between molecular weight sulphated dextran inhibits lucin sul-94% of mucin sulphatase activity at a concenp<0 01) tration of 5% wt/wt. Its Glycosidase is expressed by most colonic flora and therefore reflects faecal bacterial load. 20 The increased sulphatase/ot glucosidase ratio therefore implies a specific increase in sulphatase production or sulphatase producing bacteria rather than a non-specific increase in bacterial activity. Human serum and leucocytes have been shown not to contain mucin sulphatases. Aryl sulphatases A and B are found in human leucocytes,21 but these do not seem to be active on sulphated human colonic mucin.
There may be two possible explanations for the increased faecal sulphatase found in patients with active ulcerative colitis. The first is that an increase in faecal mucin sulphatase activity is secondary to the disease process. If the mucin sulphatase is of bacterial origin, then perturbations of the faecal flora could account for an isolated proliferation of sulphatase producing bacteria. Such perturbations may be as a result of a changed luminal environment such as increased faecal lactate.22 Most workers, however, have reported no significant differences in the faecal flora of patients with ulcerative colitis compared with controls. 23 24 The second possible explanation is that in some patients this increase in faecal sulphatase activity itself contributes to the colitic process by increasing mucin degradation and thus upsetting the balance between mucus production and bacterial degradation. Enzymatic desulphation might well be the rate limiting step in colonic mucin degradation. This could be compounded by mucus changes such as the reduced sulphation that has been shown in cultured mucosal explants from patients with ulcerative colitis25 and by the increased susceptibility of ulcerative colitis mucin to degradation by faecal extracts that has been reported by others.26 It would still be necessary to postulate an external environmental factor that triggers relapse of colitis, perhaps a gastroenteritic infection.27 This explanation is still highly speculative and would require further careful, prospective studies.
The faecal mucin sulphatase has previously been shown to be probably mainly of bacterial origin7 particularly Bacteroides spp.28 A similar mucin sulphatase has also been isolated from a Prevotella strain (RS2) isolated from pig colonic mucosa.29 A change in the colonic flora by antibiotics might be expected to change the course of ulcerative colitis if this enzyme has a role in the pathogenesis. Intravenous metronidazole30 and oral vancomycin3' have so far not been shown to be effective treatment in ulcerative colitis. Oral tobramycin has been shown in one study, however, to produce promising results when given in combination with corticosteroids. 19 Faecal mucin sulphatase is probably critical in determining the rate of degradation of secreted mucus and the increased concentrations in ulcerative colitis, whether a primary phenomenon or secondary to disease, are probably relevant to the reduction in mucus gel thickness that has recently been reported.37 Conversely, the comparative lack of increased faecal sulphatase in Crohn's disease is in keeping with the comparatively thick mucus layer37 and the comparative lack of histological mucus depletion38 that help distinguish Crohn's disease from ulcerative colitis.
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